Kenya's Esther Gitahi handed four-year ban after positive EPO test
Athletics
By
Robert Abong'o
| Oct 28, 2025
26-year-old Kenyan middle-distance runner Esther Gitahi has been banned from athletics for four years after testing positive for erythropoietin (EPO), the Athletics Integrity Unit (AIU) announced on Monday.
The Disciplinary Tribunal ruled the ban retroactive to August 6, 2024, following the athlete's adverse analytical finding and subsequent proceedings.
Gitahi's positive result came from a urine sample she provided at the B.A.A. 5K in Boston, Massachusetts, on April 13, 2024. Laboratory analysis detected EPO, a substance that stimulates red blood cell production and can boost endurance, and is prohibited under World Anti-Doping Agency (WADA) rules.
The AIU determined that she both possessed and used the substance, violating regulations.
The Disciplinary Tribunal has banned Esther Gitahi (Kenya) for 4 years from 6 August 2024 for Presence/Use of a Prohibited Substance (EPO). DQ results from 1 July 2023
Details here: https://t.co/UN2QCGb145 pic.twitter.com/BhKjVCzeQRREAD MORE
Kenya Airways and Rubis in Sh10.6b green jet fuel refinery pact
From aid to enterprise: Refugee businesses expand East Africa's economy
Taiwan firm to unveil AI computers at tech conference
How AI is transforming financial services and business in Kenya
Kiosk economy: How small traders fuelled Safaricom's Sh100b profit
Beyond promises, budget must put money into Kenyans' pockets
Mbadi's mixed signals on PAYE proposals as he defends Finance Bill, 2026
Dangote favours Mombasa over Tanzania's Tanga for Sh2tr oil refinery
Pipeline politics: Why East Africa's joint refinery dream faces slippery path
Debt burden: Inside Treasury's plan to trap Kenya with billions in hidden debt
- Athletics Integrity Unit (@aiu_athletics) October 27, 2025
After the Adverse Analytical Finding was communicated on August 6, 2024, Gitahi faced provisional suspension. She waived the right to have the B-sample tested, and the hearing proceeded with the available evidence. Gitahi admitted to using injections but contended that she did not realise they contained a banned substance.
In her statement, Gitahi explained that the injections were prescribed to manage thalassemia, a blood disorder she suspected she had. She said she sought medical advice from a Kenyan clinic in 2022 after experiencing fatigue and joint pain. Reports indicate she self-administered eight doses over about 10 months, with the positive test arising after the second round in early 2024.
The four-year sanction ends in 2028, barring any potential appeals or procedural outcomes.